US 10683279
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted A61PA61P1/16A61P3/00
Quick answer
US patent 10683279 (Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/16, A61P3/00, A61P9/00